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Background: Diabetes mellitus (DM) is risk factor for complications after orthopedic surgery.
Objectives: We tested the hypothesis that anesthesia preoperative clinic (APC) referral for elevated glycosylated hemoglobin (HbA1c)
reduces complication rate after total joint arthroplasty (TJA).
Patients and Methods: Patients (n = 203) with and without DM were chosen from 1,237 patients undergoing TJA during 2006 - 12. Patients
evaluated in the APC had surgery in 2006 - 8 regardless of HbA1c (uncontrolled). Those evaluated between in subsequent two-year intervals
were referred to primary care for HbA1c ≥ 10% and ≥ 8%, respectively, to improve DM control before surgery. Complications and mortality
were quantified postoperatively and at three, six, and twelve months. Length of stay (LOS) and patients requiring a prolonged LOS (> 5
days) were recorded.
Results: Patients (197 men, 6 women) underwent 71, 131, and 1 total hip, knee, and shoulder replacements, respectively. Patients undergoing
TJA with uncontrolled HbA1c and those with HbA1c < 10%, but not those with HbA1c < 8%, had a higher incidence of coronary disease and
hypercholesterolemia than patients without DM. An increase in complication rate was observed in DM patients with uncontrolled HbA1c
versus patients without DM (P < 0.001); the complication rate progressively decreased with tighter HbA1c control. More DM patients
with preoperative HbA1c that was uncontrolled or ≥ 10% required prolonged LOS versus those without DM (P < 0.001 and P = 0.0404,
respectively).
Conclusions: APC referral for elevated HbA1c reduces complication rate and the incidence of prolonged hospitalization during the first
year after surgery in diabetics undergoing TJA.
Keywords: Diabetes Mellitus; Glycosylated Hemoglobin; Orthopedic Surgery; Arthroplasty

1. Background
Diabetes mellitus is an important risk factor for postoperative complications after orthopedic surgery (1-5).
Patients with diabetes undergoing primary or revision
total joint arthroplasty had higher hospital costs, fewer routine discharges, and an increased risk of stroke,
pneumonia, ileus, urinary tract infection, and transfusion than those without the disease (1, 5). Uncontrolled
diabetes [as determined using patient self-reporting of
blood glucose concentration, glycosylated hemoglobin
(HbA1c) level, and end-organ damage] was shown to be
particularly harmful, as the incidence of morbidity and
mortality was greater in diabetic patients undergoing
arthroplasty with poorly- versus well-controlled disease
(4). Recent evidence further suggests that poor long-term
control of diabetes may increase postoperative complications in orthopedic and other types of surgery (2, 3). A
preoperative HbA1c ≥ 7.1% was implicated as a major risk
factor for all-cause complications in diabetic patients

undergoing total joint arthroplasty (2), whereas a HbA1c
level ≤ 7.0% may decrease the risk of perioperative and
long-term complications in patients undergoing cardiac and noncardiac surgery (6-9). Anesthesia-directed
preoperative clinics evaluation enhance operating room
efficiency, improve patient education and satisfaction,
reduce unnecessary testing and consultation, and decrease adverse perioperative events (10-13) in patients undergoing elective surgery, including those scheduled for
orthopedic procedures (14). Whether the anesthesia preoperative evaluation clinic and referral to primary care
are capable of reducing the adverse effects of diabetes by
improving chronic control of blood glucose concentration is unknown.

2. Objectives
The authors tested the hypothesis that preoperative
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evaluation clinic screening and referral of veterans with
poorly controlled diabetes to their primary care physicians to obtain better long-term control of the disease
before surgery reduces complication rate during the first
year after elective total joint arthroplasty.

3. Patients and Methods
The Institutional Review Boards of Clement J. Zablocki
Veterans Affairs Medical Center and Marquette University
reviewed and approved the protocol. Written informed
consent was waived because of the retrospective, observational study design. The study protocol conforms to
the ethical guidelines of the 1975 Declaration of Helsinki.
The electronic medical records of all patients undergoing total joint arthroplasty (n = 1,237) at the Zablocki Veterans Affairs Medical Center between January 1, 2006 and
December 31, 2012 were identified using an orthopedic
surgery database. Two hundred and three patients with
and without diabetes (n = 103 and n = 100, respectively)
undergoing elective joint arthroplasty were randomly
chosen from this cohort. Patients undergoing revision arthroplasty and those with preexisting wound infections
were excluded from analysis. All demographic and clinical outcome data for each patient were obtained from
simultaneous review of the electronic medical record by
three investigators (PJK, JN, AO) to assure consistency. Patients with diabetes were required to have a HbA1c level
recorded in the medical record within six months before
surgery. In January, 2009, based on emerging data about
the possible importance of long-term control of blood
glucose concentration on outcomes after surgery (4, 7,
8), the preoperative evaluation clinic director (PJK) began to recommend to his patients that those with HbA1c
≥ 10 should delay their procedures. These patients were
counseled to return to their primary care physicians
or the endocrinology clinic to obtain better long-term
control of blood glucose concentration before proceeding with elective total joint arthroplasty. An analysis of
pilot data conducted two years later suggested that this
approach for patients with poorly controlled diabetes
may be reducing the rate of complications. As a result,
the threshold for referral was reduced to HbA1c ≥ 8% during 2011 and 2012. We chose a threshold value HbA1c ≥ 8%
(rather than the 7% level recommended by the American
Diabetes Association (15)) because aggressive compared
with moderate glycemic control may inadvertently cause
hypoglycemia and increase perioperative morbidity and
mortality in high-risk patients (16, 17), such as elderly
veterans undergoing total joint arthroplasty. Surgical
site or urinary tract infections (verified with appropriate
culture and sensitivity), delayed wound healing (including inflammation, dehiscence, and chronic drainage), requirement for transfusion of autologous blood products,
unplanned prolonged hospitalization for inadequate
pain control, chronic pain requiring long-term management, pneumonia, deep venous thrombosis with or with2

out pulmonary embolism, cardiovascular complications
including myocardial ischemia or infarction and atrial
or ventricular arrhythmias requiring medical treatment
(antiarrhythmic medications, cardioversion, electrophysiology intervention, or device placement), cerebrovascular accident, and mortality were quantified during
the immediate postoperative period and at the three,
six, and twelve month orthopedic surgery follow-up appointments. Hospital length of stay and the number of
patients requiring a prolonged length of stay (defined as
greater than five days) after surgery were also recorded.
Diabetic patients undergoing total joint arthroplasty in
the current investigation were treated with either continuous infusions or sliding-scale bolus doses of insulin
to maintain blood glucose concentration between 140 to
180 mg/dL during and after surgery regardless of preoperative HbA1c, (18, 19). “Tighter” control of blood glucose
concentration was avoided because of the potential risk
of hypoglycemia. Consultant internists or endocrinologists were responsible for postoperative diabetic care in
these patients and used similar methods and goals for
control of blood glucose concentration during hospitalization. Primary care physicians or endocrinologists
managed blood glucose concentration using established
American Diabetes Association guidelines 15 after the patients were discharged from the hospital.

3.1. Statistical Analysis

A power analysis conducted before beginning the study
indicated that a group size ≥ 65 (patients with versus
without diabetes) was required for a minimal difference
of 20% in all-cause complication rate between patients
with or without diabetes (alpha error < 0.05; beta error
< 0.20) with a power of 95%. Continuous data between
groups were analyzed using analysis of variance (ANOVA)
followed by Bonferroni’s test for differences between
means. All continuous data are presented as mean ± standard deviation. Differences in categorical variables were
determined using chi-square analysis. Categorical variables are presented as raw numbers or percentages. Linear regression analysis was used to assess the correlation
between the number of complications per patient and
HbA1c. Stat Plus: Mac software (Analyst Soft, Alexandria,
Virginia, USA) was used for statistical analysis. The null
hypothesis was rejected when P < 0.05.

4. Results

Veterans (197 men and 6 women) underwent 71, 131, and
1 total hip, knee, and shoulder replacements, respectively
(Table 1). The demographics in patients without diabetes
were similar to those with diabetes irrespective of HbA1c
control (Table 1). Serum creatinine was significantly
greater in patients with uncontrolled diabetes undergoing elective surgery compared with patients who were
not diabetic (P = 0.00121). Patients with diabetes with
uncontrolled HbA1c and those with HbA1c < 10%, but not
Anesth Pain Med. 2015;5(3):e24376
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< 8%, had a higher incidence of coronary artery disease
and hypercholesterolemia and were more likely to receive ACE inhibitors or ARB. An increase in complication
rate was observed in diabetic patients with uncontrolled
HbA1c versus patients without diabetes (P < 0.0001), but
this elevated complication rate progressively declined
with tighter HbA1c control (Tables 1 and 2). Diabetic patients with preoperative uncontrolled HbA1c or HbA1c <

10% also required prolonged length of stay, but the mean
length of stay was similar between groups. There were no
differences in the incidence of system-specific complications between diabetic patients regardless of HbA1c control compared with patients without diabetes (Table 3).
A significant correlation was observed between the number (n) of complications per patient and HbA1c (n = 0.339
× HbA1c – 1.46; r = 0.32, P < 0.01).

Table 1. Demographic, Historical, and Medication data for Patients With and Without Diabetes Based on A1c Control Before Elective
total Joint Surgery a, b
Variables
Number
Surgery Type (Hip, Knee, Shoulder)
Gender
Male
Female

Age, y

Weight, kg
Height, cm

Body Mass Index, kg/m2
A1c, %
Hematocrit, %
Creatinine, mg/dL
Potassium, mEq/L
Length of Stay, d
Prolonged Length of Stay
Complication Rate
Coronary Artery Disease
Hypertension
Hypercholesterolemia
Chronic Obstructive Pulmonary
Disease
Peripheral Vascular Disease
Tobacco Use
Insulin
Oral Hypoglycemic Drug
Beta-Adrenoceptor Antagonist
Calcium Channel Blocker
Nitrate
ACE inhibitor or ATII blocker

-DM

+DM No Referral for A1C +DM Referral for A1c < 10% +DM Referral for A1c < 8%

100

55

32

16

41/58/1

14/41/0

11/21/0

6/10/0

99

52

31

15

1

3

1

1

65 ± 9

66 ± 10

66 ± 8

66 ± 10

102 ± 20

103 ± 21

113 ± 28

115 ± 26

178 ± 7

176 ± 9

177 ± 9

177 ± 10

32 ± 6

34 ± 7

36 ± 7 c

36 ± 7 c

5.7 ± 0.4

7.0 ± 1.0 c

6.9 ± 0.8c

6.8 ± 0.6 c

42 ± 4

42 ± 5

41 ± 4

41 ± 4

1.04 ± 0.25

1.24 ± 0.40 c

1.04 ± 0.31 d

0.88 ± 0.22 d

4.1 ± 0.4

4.2 ± 0.4

4.1 ± 0.4

4.1 ± 0.4

7.6 ± 6.4

10.2 ± 11.4

8.3 ± 5.7

8.3 ± 5.9

23
0.36 ± 0.63

31 c

1.27 ± 1.18 c

14

14 c

71

45

14 c

0.78 ± 1.01
13 c
27

6
0.50 ± 0.89
4
14

42

33 c

23 c

5

6

4

0

4

3

1

1

29

16

8

2

0

11

7

7

0

9

21

23 d

10

34

24

17

6

23

7

7

3

1

6

5

2

32

32c

22 c

8

a Abbreviations: + and - DM, with and without diabetes mellitus, respectively; N, number; A1c, glycosylated hemoglobin concentration; ACE,
angiotensin converting enzyme; ATII, angiotensin II.
b Continuous data are mean ± standard deviation; categorical data are numbers.
c Significantly (P < 0.05) different from – DM.
d Significantly (P < 0.05) different from + DM No Control.
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Table 2. P Values for Statistics in Table 1 a,b
Variables

Type of Surgery
Age

Weight
Height

Body Mass Index
A1c

Hematocrit
Creatinine
Potassium

Length of Stay

Prolonged Length of Stay
Complication Rate

Coronary Artery Disease
Hypertension

Hypercholesterolemia
Chronic Obstructive
Pulmonary Disease
Peripheral Vascular
Disease
Tobacco Use
Insulin

Oral Hypoglycemic Drug
Beta-Adrenoceptor
Antagonist

Calcium Channel Blocker
Nitrate

ACE inhibitor or ATII
blocker

-DM vs. +DM No
Referral

-DM vs. +DM
Referral for
A1c < 10%

-DM vs. +DM
Referral for
A1c < 8%

+DM No Referral
vs. +DM Referral
for A1c < 10%

+DM No Referral
vs. +DM Referral
for A1c < 8%

+DM Referral for A1c
< 10% vs. Referral
for A1c < 8%

0.0783

0.647

1

1

1

1

0.522

-

0.920

1

1

1

0.121

0.187

1

0.362

0.386

1

0.667

1

1

1

1

1

1

0.00440

0.0142

0.100

0.116

0.791

< 0.00001

< 0.00001

< 0.00001

1

1

1

1

1

1

1

1

1

0.00121

1

0.317

0.0224

0.00038

0.592

0.594

1

1

1

1

1

0.332

1

1

1

1

1
0.920

< 0.001

0.0404

-

0.362

0.296

< 0.0001

0.124

1

0.0826

0.152

1

0.120

0.00272

-

0.218

-

0.313

0.196

0.203

0.764

1

-

-

0.048

0.00617

0.427

0.377

1

0.450

-

-

-

-

-

-

-

-

-

-

-

-

0.863

0.823

-

0.863

-

-

-

-

-

1

-

-

-

-

-

0.00497

0.150

0.740

0.310

0.0843

1

0.527

0.888

0.476

0.181

0.920

-

0.413

-

-

-

-

-

-

-

-

0.00273

0.000512

0.262

0.454

0.764

0.343

a Abbreviations: + and – DM, with and without diabetes mellitus, respectively; A1c, glycosylated hemoglobin concentration; ACE, angiotensin
converting enzyme; ATII, angiotensin II.
b Continuous data were analyzed using ANOVA followed by Bonferroni test for differences between means. Categorical data were analyzed using the
Chi-square test (expected group size less than 5 were not analyzed).

Table 3. Incidence Proportion of Postoperative Complications in Patients With and Without Diabetes Based on A1c Control Before
elective Total Joint Surgery a
Variables
Number
Cardiac

Pulmonary
Neurologic

Urinary Tract Infection
Transfusion
Pain

Surgical Site Infection

Delayed Wound Healing
Mortality

-DM

+DM No Referral

+DM Referral for A1c < 10%

+DM Referral for A1c < 8%

100

55

32

16

0.06

0.11

0.13

0.06

0

0

0.02

0.07

0.16

0.02

0.07

0.06

0.27

0.19

0.01
0.11

0.04
0.05

0.04
0.01

0.07
0.27
0.15

0.18

0.07

0.13
0

0.19

0.06

0.19

0.06

0.06

0

0.03

0.19

a Abbreviations: + and – DM, with and without diabetes mellitus, respectively; A1c, glycosylated hemoglobin concentration.

4

0
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5. Discussion
The current results confirm the findings of several previous studies (1-5) indicating that is diabetes an important risk factor for postoperative complications. The results further demonstrate that more stringent long-term
control of the disease directed by preoperative anesthesia clinic referral reduces the incidence of prolonged hospitalization and complication rate during the first year
after surgery in patients undergoing elective total joint
arthroplasty. Several previous large-scale clinical trials established a link between diabetes and major postoperative complications in orthopedic surgery patients. A
study of 751,340 patients from the United States Nationwide Inpatient Sample undergoing primary or revision
total knee or hip arthroplasty revealed that patients with
diabetes were more likely to develop pneumonia, suffer
cerebrovascular accidents, require autologous blood
product transfusion, and have greater hospital costs than
those without diabetes (1). Marchant et al. showed that
the risk of stroke, urinary tract infection, ileus, postoperative hemorrhage, transfusion, prolonged hospitalization, and mortality was greater in patients with poorly
controlled diabetes undergoing total joint arthroplasty
compared with those whose diabetes was well controlled
(4). Fewer infectious complications (particularly those
involving the urinary tract), but not the risk of revision,
deep venous thrombosis, pulmonary embolism, or prosthesis infection, were also observed in diabetic patients
undergoing orthopedic surgery when HbA1c < compared
with ≥ 7% (3, 20, 21). When complicated by end-organ
damage (presumably resulting from poor long-term control), diabetes was shown to be a strong predictor (odds
ratio of 1.94) of 90-day overall complication risk in a tenyear study of 138,399 patients undergoing total hip arthroplasty in California (5). More recently, Harris et al.
retrospectively examined 6,088 diabetic patients treated
in the Veterans Health Administration system and
showed that there was linear relationship between HbA1c
and complications after total joint arthroplasty (2). Preoperative HbA1c ≥ 7 also increased the relative risk of
complications and 90-day mortality after surgery. The
current results demonstrating a significant correlation
between the number of complications sustained per patient and long-term control of blood glucose concentration also verified the previously observed linear relationship between complication rate and HbA1c that was
reported in veterans undergoing total joint arthroplasty
(2). Other studies of diabetic patients undergoing cardiac
(6-8, 22) and major noncardiac (23-26) have reached similar conclusions about the importance of long-term control of blood glucose concentration on complication rate
and outcome. Identification and optimization of co-existing diseases, including diabetes, are important goals in
the anesthesia preoperative clinic setting (27, 28). To date,
short-term control of blood glucose concentration, most
often entailing avoidance of hypoglycemia and profound
Anesth Pain Med. 2015;5(3):e24376

hyperglycemia, and management of the cardiovascular
and renal sequelae of diabetes receive primary attention
during preoperative assessment of patients with the disease (29), whereas attempts to gain tighter long-term
control have generally not received emphasis. From this
perspective, the objective of the current investigation
was to examine whether preoperative clinic identification of veterans with poor long-term control of diabetes
(as defined by HbA1c ≥ 10 in 2009-10 and ≥ 8 in 2011-12) and
subsequent referral of these patients to primary care for
improved control of their disease would reduce postoperative complications determined up to one year after
elective total joint arthroplasty. Our results support this
contention, as the simple decision to refer these patients
with poorly controlled diabetes from the anesthesia preoperative clinic to primary care or endocrinology resulted in progressive reductions in complication rate and the
number of patients requiring a prolonged hospital stay.
Indeed, the rate of complications in diabetics when all
patients with HbA1c ≥ 8 were referred to primary care
(0.50 ± 0.89) was statistically indistinguishable from that
observed in their healthy peers without the disease (0.36
± 0.63; P = 1) when the current relatively small sample size
was considered. Whether use of American Diabetes Association recommendations (HbA1c < 7%) (15) for chronic
glycemic control would further reduce complication rate
remains to be determined. However, the current data
suggest that moderate, less rigorous long-term control of
blood glucose concentration substantially improves outcome in the setting of elective total joint surgery by reducing complication rate to values similar to those observed in patients without diabetes. The current results
in diabetic veterans support the general observations of
Kamal et al. indicating that evaluation of patients scheduled to undergo complex orthopedic surgery in an anesthesia preoperative clinic reduces mortality, unplanned
intensive care unit admissions, intensive care and high
dependency unit lengths of stay, and cost (14). The current results should be interpreted within the constraints
of several potential limitations. Almost all of patients enrolled in the study were men (97%) because of the Veterans Affairs population, and whether the current findings
can also be extended to women is unknown. The sample
size studied here was relatively small and was unable to
distinguish differences in organ-specific complications
between groups as a result. A larger study including
women would be useful to determine such potential differences in end-organ complications and whether the
observed complications are gender-specific. Nevertheless, it is clear, based on the observations of several largescale clinical studies, that diabetes is a risk factor for cardiac, neurological, infectious, and wound healing
complications after orthopedic surgery (1, 2, 4, 5). Veterans with uncontrolled or poorly controlled diabetes were
significantly more likely to have coronary artery disease
5
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and hypercholesterolemia than those in whom diabetic
control was more rigorous. It is likely that the greater incidence of cardiovascular disease contributed to the
higher complication rate in patients with poorly versus
moderately controlled diabetes. The results also require
qualification because patients with diabetes were required to have a HbA1c level recorded within six months
before surgery. HbA1c most likely reflects chronic blood
glucose control over a three-month interval (15), but
many patients in our hospital often do not receive routine primary care to allow this frequency of HbA1c sampling. As a result, a six-month HbA1c sampling interval
was chosen to indicate chronic preoperative control of
blood glucose concentration. Whether the current results in patients undergoing elective orthopedic surgery
are applicable in other surgical patients is unknown, but
diabetes has been identified as a major risk factor for
perioperative morbidity and mortality in noncardiac and
cardiac surgery (6-8) and it seems likely that improved
long-term glycemic control may also exert beneficial effects on outcome in other groups of surgery patients
when approached prospectively. Finally, fewer total joint
operations were performed in diabetic veterans with
tighter chronic control of blood glucose concentration.
The current investigation did not consider the benefits of
delaying total joint replacement to obtain more stringent glycemic control in diabetic patients versus the relative risk of continued, often quite severe, functional limitations occurring as a result of primary chronic joint
pathology. In summary, the current results demonstrate
that anesthesia preoperative clinic referral of diabetic
veterans to primary care for more rigorous glycemic control before elective total joint arthroplasty reduces the
incidence of prolonged hospitalization and complication rate during the first year after surgery. These data
support the contention that anesthesia preoperative
clinic evaluation and intervention may be directly linked
to improved patient outcome.
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